Cancer Biopharmaceuticals Market Report

Global and Region Cancer Biopharmaceuticals Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：172
  • REPORT CODE：GMM961401
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Cancer is a complex invasive genetic disease that causes significant mortality rate worldwide. Cancer drugs are the primary concern in terms of drug development trends.

    The report details the trend, potential and market size of Cancer Biopharmaceuticals market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Biopharmaceuticalsmarket, defines the market attractiveness level of Cancer Biopharmaceuticals market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Cancer Biopharmaceuticals industry, describes the types of Cancer Biopharmaceuticals market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Biopharmaceuticals market and the development prospects and opportunities of Cancer Biopharmaceuticals industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Biopharmaceuticals market in Chapter 13.

    By Player:

    • AstraZeneca

    • Bristol Myers Squibb

    • Alexion Pharmaceuticals

    • Elusys Therapeutics

    • Novartis

    • Johnson & Johnson

    • Sanofi

    • Boehringer Ingelheim

    • GlaxoSmithKline

    • Mylan

    • Merck

    • Agios Pharmaceuticals

    • LEO Pharma

    • Pfizer

    • Eli Lilly

    By Type:

    • Biologics

    • Biosimilars

    By End-User:

    • Liquid Cancers

    • Solid Cancers

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Cancer Biopharmaceuticals Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Cancer Biopharmaceuticals Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Cancer Biopharmaceuticals Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Cancer Biopharmaceuticals Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Cancer Biopharmaceuticals Market Analysis and Outlook to 2022

    • 7.1 Global Cancer Biopharmaceuticals Consumption (2017-2022)

    • 7.2 United States Cancer Biopharmaceuticals Consumption (2017-2022)

    • 7.3 Europe Cancer Biopharmaceuticals Consumption (2017-2022)

    • 7.4 China Cancer Biopharmaceuticals Consumption (2017-2022)

    • 7.5 Japan Cancer Biopharmaceuticals Consumption (2017-2022)

    • 7.6 India Cancer Biopharmaceuticals Consumption (2017-2022)

    • 7.7 South Korea Cancer Biopharmaceuticals Consumption (2017-2022)

    8 Region and Country-wise Cancer Biopharmaceuticals Market Analysis and Outlook to 2028

    • 8.1 Global Cancer Biopharmaceuticals Consumption Forecast (2022-2028)

    • 8.2 United States Cancer Biopharmaceuticals Consumption Forecast (2022-2028)

    • 8.3 Europe Cancer Biopharmaceuticals Consumption Forecast (2022-2028)

    • 8.4 China Cancer Biopharmaceuticals Consumption Forecast (2022-2028)

    • 8.5 Japan Cancer Biopharmaceuticals Consumption Forecast (2022-2028)

    • 8.6 India Cancer Biopharmaceuticals Consumption Forecast (2022-2028)

    • 8.7 South Korea Cancer Biopharmaceuticals Consumption Forecast (2022-2028)

    9 Global Cancer Biopharmaceuticals Market Outlook by Types and Applications to 2022

    • 9.1 Global Cancer Biopharmaceuticals Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Biologics Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Biosimilars Consumption and Growth Rate (2017-2022)

    • 9.2 Global Cancer Biopharmaceuticals Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Liquid Cancers Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Solid Cancers Consumption and Growth Rate (2017-2022)

    10 Global Cancer Biopharmaceuticals Market Outlook by Types and Applications to 2028

    • 10.1 Global Cancer Biopharmaceuticals Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Biologics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Cancer Biopharmaceuticals Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Liquid Cancers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Solid Cancers Consumption Forecast and Growth Rate (2022-2028)

    11 Global Cancer Biopharmaceuticals Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Cancer Biopharmaceuticals Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Cancer Biopharmaceuticals Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Cancer Biopharmaceuticals Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Cancer Biopharmaceuticals Market Competitive Analysis

    • 14.1 AstraZeneca

      • 14.1.1 AstraZeneca Company Details

      • 14.1.2 AstraZeneca Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 AstraZeneca Cancer Biopharmaceuticals Product and Service

    • 14.2 Bristol Myers Squibb

      • 14.2.1 Bristol Myers Squibb Company Details

      • 14.2.2 Bristol Myers Squibb Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bristol Myers Squibb Cancer Biopharmaceuticals Product and Service

    • 14.3 Alexion Pharmaceuticals

      • 14.3.1 Alexion Pharmaceuticals Company Details

      • 14.3.2 Alexion Pharmaceuticals Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Alexion Pharmaceuticals Cancer Biopharmaceuticals Product and Service

    • 14.4 Elusys Therapeutics

      • 14.4.1 Elusys Therapeutics Company Details

      • 14.4.2 Elusys Therapeutics Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Elusys Therapeutics Cancer Biopharmaceuticals Product and Service

    • 14.5 Novartis

      • 14.5.1 Novartis Company Details

      • 14.5.2 Novartis Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Novartis Cancer Biopharmaceuticals Product and Service

    • 14.6 Johnson & Johnson

      • 14.6.1 Johnson & Johnson Company Details

      • 14.6.2 Johnson & Johnson Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Johnson & Johnson Cancer Biopharmaceuticals Product and Service

    • 14.7 Sanofi

      • 14.7.1 Sanofi Company Details

      • 14.7.2 Sanofi Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sanofi Cancer Biopharmaceuticals Product and Service

    • 14.8 Boehringer Ingelheim

      • 14.8.1 Boehringer Ingelheim Company Details

      • 14.8.2 Boehringer Ingelheim Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Boehringer Ingelheim Cancer Biopharmaceuticals Product and Service

    • 14.9 GlaxoSmithKline

      • 14.9.1 GlaxoSmithKline Company Details

      • 14.9.2 GlaxoSmithKline Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 GlaxoSmithKline Cancer Biopharmaceuticals Product and Service

    • 14.10 Mylan

      • 14.10.1 Mylan Company Details

      • 14.10.2 Mylan Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Mylan Cancer Biopharmaceuticals Product and Service

    • 14.11 Merck

      • 14.11.1 Merck Company Details

      • 14.11.2 Merck Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Merck Cancer Biopharmaceuticals Product and Service

    • 14.12 Agios Pharmaceuticals

      • 14.12.1 Agios Pharmaceuticals Company Details

      • 14.12.2 Agios Pharmaceuticals Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Agios Pharmaceuticals Cancer Biopharmaceuticals Product and Service

    • 14.13 LEO Pharma

      • 14.13.1 LEO Pharma Company Details

      • 14.13.2 LEO Pharma Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 LEO Pharma Cancer Biopharmaceuticals Product and Service

    • 14.14 Pfizer

      • 14.14.1 Pfizer Company Details

      • 14.14.2 Pfizer Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Pfizer Cancer Biopharmaceuticals Product and Service

    • 14.15 Eli Lilly

      • 14.15.1 Eli Lilly Company Details

      • 14.15.2 Eli Lilly Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Eli Lilly Cancer Biopharmaceuticals Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Cancer Biopharmaceuticals

    • Figure Cancer Biopharmaceuticals Picture

    • Table Global Cancer Biopharmaceuticals Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Biopharmaceuticals Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Biopharmaceuticals Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Cancer Biopharmaceuticals Consumption by Country (2017-2022)

    • Figure United States Cancer Biopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table Europe Cancer Biopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure China Cancer Biopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Japan Cancer Biopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure India Cancer Biopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cancer Biopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Biopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure United States Cancer Biopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cancer Biopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Cancer Biopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cancer Biopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cancer Biopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cancer Biopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biologics Consumption and Growth Rate (2017-2022)

    • Figure Global Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure Global Liquid Cancers Consumption and Growth Rate (2017-2022)

    • Figure Global Solid Cancers Consumption and Growth Rate (2017-2022)

    • Figure Global Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liquid Cancers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Solid Cancers Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Cancer Biopharmaceuticals Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Cancer Biopharmaceuticals Export by Region (Top 5 Countries) (2017-2028)

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Cancer Biopharmaceuticals Product and Service

    • Table Bristol Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol Myers Squibb Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol Myers Squibb Cancer Biopharmaceuticals Product and Service

    • Table Alexion Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Alexion Pharmaceuticals Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alexion Pharmaceuticals Cancer Biopharmaceuticals Product and Service

    • Table Elusys Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Elusys Therapeutics Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Elusys Therapeutics Cancer Biopharmaceuticals Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Cancer Biopharmaceuticals Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Cancer Biopharmaceuticals Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Cancer Biopharmaceuticals Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Cancer Biopharmaceuticals Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Cancer Biopharmaceuticals Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Cancer Biopharmaceuticals Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Cancer Biopharmaceuticals Product and Service

    • Table Agios Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Agios Pharmaceuticals Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agios Pharmaceuticals Cancer Biopharmaceuticals Product and Service

    • Table LEO Pharma (Foundation Year, Company Profile and etc.)

    • Table LEO Pharma Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table LEO Pharma Cancer Biopharmaceuticals Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Cancer Biopharmaceuticals Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Cancer Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Cancer Biopharmaceuticals Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US